Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in<i>in vitro</i>fertilization patients
Sezai Şahmay(Istanbul University-Cerrahpaşa), Tülay İrez(Istanbul University), Begüm Aydoğan Mathyk(University of South Florida), Onur Güralp(Klinikum Oldenburg), İsmail Çepni(Istanbul University), Engin Oral
Cited by 17
Related Papers
ESHRE guideline: endometriosis
|Human Reproduction Open|2022|1.5k
Serum AMH levels and insulin resistance in women with PCOS
|European Journal of Obstetrics & Gynecology and Reproductive Biology|2018|95
Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
|European Journal of Obstetrics & Gynecology and Reproductive Biology|2013|86
Clinical characteristics and pregnancy outcomes of Syrian refugees: a case–control study in a tertiary care hospital in Istanbul, Turkey
|Archives of Gynecology and Obstetrics|2016|77
Elevated serum levels of anti‐Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome
|Acta Obstetricia Et Gynecologica Scandinavica|2013|69